Daily Current Affairs / Alembic Pharma gets USFDA nod for generic cancer treatment injection:
Category : Science and Tech Published on: July 02 2025
Alembic Pharmaceuticals has secured final approval from the USFDA for its generic Doxorubicin Hydrochloride Liposome injection (20 mg/10 mL and 50 mg/25 mL). This key oncology treatment approval under ANDA allows Alembic to market a cost-effective alternative for various cancers in the US.
